Literature DB >> 20570289

Early stroke treatment with IV t-PA associated with early recanalization.

Kazumi Kimura1, Yasuyuki Iguchi, Kensaku Shibazaki, Junya Aoki, Masao Watanabe, Noriko Matsumoto, Shinji Yamashita.   

Abstract

PURPOSE: Time from stroke onset to treatment (OTT) is potentially an important factor affecting subsequent outcome in patients treated with t-PA. The aim of the study was to assess the correlation between OTT and early recanalization rate after IV-t-PA therapy.
METHODS: Consecutive stroke patients treated with t-PA within 3h of onset were prospectively studied. Patients with major brain artery occlusion on MRA before t-PA infusion were enrolled. The correlation between OTT and the early recanalization rate within 1h after t-PA infusion was determined.
RESULTS: 102 patients (M1 occlusion, 41 patients; M2, 19; ICA, 31; BA, 8; and PCA, 3) were enrolled. Follow-up MRA within 1h after t-PA infusion showed early recanalization in 42 (41.2%) patients (complete in 13 patients, partial in 29). The early recanalization rate was 53.8% with OTT <or=100 min, 57.1% in 101-110 min, 50.0% in 111-120 min, 63.6% in 121-130 min, 33.3% in 131-140 min, 30.0% in 141-150 min, 36.4% in 151-160 min, 18.2% in 161-170 min, and 32.0% in 171-180 min. OTT was negatively correlated with the early recanalization rate (r=-0.767, P=0.0301). After adjusting the presence of age (>74), ICA occlusion, baseline NIHSS score (<10), and glucose (>150 mg/dl), adjusted OR for early recanalization of OTT <or=130 min against OTT >130-180 min was 2.97 (95% CI 1.27-6.96, P=0.012).
CONCLUSION: Early recanalization depended on time from stroke onset to IV-t-PA administration. Thus, t-PA should be given to acute stroke patients as soon as possible. Copyright (c) 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20570289     DOI: 10.1016/j.jns.2010.05.012

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  5 in total

1.  Stent retrievers in acute ischemic stroke: complications and failures during the perioperative period.

Authors:  G Gascou; K Lobotesis; P Machi; I Maldonado; J F Vendrell; C Riquelme; O Eker; G Mercier; I Mourand; C Arquizan; A Bonafé; V Costalat
Journal:  AJNR Am J Neuroradiol       Date:  2013-10-24       Impact factor: 3.825

2.  An old thrombus may potentially identify patients at higher risk of poor outcome in anterior circulation stroke undergoing thrombectomy.

Authors:  Jia'xing Lin; Min Guan; Yu Liao; Liang Zhang; Hong'yu Qiao; Li'an Huang
Journal:  Neuroradiology       Date:  2022-10-21       Impact factor: 2.995

3.  Effects of a school-based stroke education program on stroke-related knowledge and behaviour modification-school class based intervention study for elementary school students and parental guardians in a Japanese rural area.

Authors:  Suzuka Kato; Tomonori Okamura; Kazuyo Kuwabara; Hidehiro Takekawa; Masanori Nagao; Mitsumasa Umesawa; Daisuke Sugiyama; Naomi Miyamatsu; Tenyu Hino; Shinichi Wada; Takuro Arimizu; Toru Takebayashi; Gen Kobashi; Koichi Hirata; Chiaki Yokota; Kazuo Minematsu
Journal:  BMJ Open       Date:  2017-12-21       Impact factor: 2.692

4.  Timing of Recanalization and Functional Recovery in Acute Ischemic Stroke.

Authors:  Georgios Tsivgoulis; Maher Saqqur; Vijay K Sharma; Alejandro Brunser; Jürgen Eggers; Robert Mikulik; Aristeidis H Katsanos; Theodore N Sergentanis; Konstantinos Vadikolias; Fabienne Perren; Marta Rubiera; Reza Bavarsad Shahripour; Huy Thang Nguyen; Patricia Martínez-Sánchez; Apostolos Safouris; Ioannis Heliopoulos; Ashfaq Shuaib; Carol Derksen; Konstantinos Voumvourakis; Theodora Psaltopoulou; Anne W Alexandrov; Andrei V Alexandrov
Journal:  J Stroke       Date:  2020-01-31       Impact factor: 6.967

5.  Histopathologic composition of cerebral thrombi of acute stroke patients is correlated with stroke subtype and thrombus attenuation.

Authors:  Joris M Niesten; Irene C van der Schaaf; Lievay van Dam; Aryan Vink; Jan Albert Vos; Wouter J Schonewille; Peter C de Bruin; Willem P T M Mali; Birgitta K Velthuis
Journal:  PLoS One       Date:  2014-02-11       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.